Recall Register

Device recall: AngioJet Ultra Consoles-Thrombectomy System UPN: 105650-001D 105650-001H 105650-001R 105650-001Z 105650-002R…

Class II FDA enforcement event 84363. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Missing Directions for Use (DFU) - Consoles shipped to customers without the required Operator's Manual.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Boston Scientific Corporation started this device recall on 8 Nov 2019. The firm address in the FDA record is in Marlborough, MA. FDA put the recall in Class II. FDA event 84363 has 1 product record. The first FDA enforcement report date is 25 Dec 2019. The record gives the status Terminated, with the termination date 24 Mar 2021.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Worldwide distribution - US Nationwide distribution and country of Canada.

Recalling firm

Boston Scientific Corporation, Marlborough, MA.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 84363: product records
Recall numberProductQuantityClassStatusReport date
Z-0717-2020AngioJet Ultra Consoles-Thrombectomy System UPN: 105650-001D 105650-001H 105650-001R 105650-001Z 105650-002R 105650-004H 105650-004R 105650-007R 105650-009R 105650-024H 105650-024Z 105650-025 105650-025H 105650-025R 105650-026R Product Usage - The AngioJet allows for percutaneous removal of thrombus located in…169 units ((OUS: 44 US: 125)Class IITerminated25 Dec 2019

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Device events that started in 2019
968
Share of these events in Class II
88%
Product records in this event
1Median of the firm: 2
Events of the firm on the register
162

Other events of the firm

Official channels

Cite this page

Recall Register. FDA enforcement event 84363. https://recallregister.com/fda/ii/84363/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Worldwide distribution - US Nationwide distribution and country of Canada.
What quantity of product is in FDA event 84363?
The FDA record gives this quantity: 169 units ((OUS: 44 US: 125)
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2019 have the same class?
88% of the 968 device events that started in 2019 are in Class II.